Insulet Corp: Form 10-K for the period ended Dec 31, 2021
Filed with the SEC on Feb 24, 2022 and accepted by EDGAR at Feb 23, 2022, 18:06 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2021-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2021-01-01 to 2021-12-31 | $1.10bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months2021-01-01 to 2021-12-31 | $346.7m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 12 months2021-01-01 to 2021-12-31 | $752.1m | us-gaap:GrossProfit |
| Research and development | 12 months2021-01-01 to 2021-12-31 | $160.1m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 12 months2021-01-01 to 2021-12-31 | $466.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months2021-01-01 to 2021-12-31 | $126.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2021-01-01 to 2021-12-31 | $61.7m | us-gaap:InterestExpense |
| Income tax | 12 months2021-01-01 to 2021-12-31 | $3.7m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2021-01-01 to 2021-12-31 | $16.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2021-01-01 to 2021-12-31 | $0.24 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2021-01-01 to 2021-12-31 | $0.25 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2021-01-01 to 2021-12-31 | 68,579,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2021-01-01 to 2021-12-31 | −$68.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2021-01-01 to 2021-12-31 | $111.9m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Current assets | At period end2021-12-31 | $1.33bn | us-gaap:AssetsCurrent |
| Total assets | At period end2021-12-31 | $2.05bn | us-gaap:Assets |
| Current liabilities | At period end2021-12-31 | $228.8m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2021-12-31 | $1.49bn | us-gaap:Liabilities |
| Long-term debt | At period end2021-12-31 | $1.25bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2021-12-31 | $25.1m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2021-12-31 | $556.3m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001145197-22-000012. Last ingested by Listed: Nov 14, 2026, 12:01 ET. Listed shows no prices and gives no investment advice.